The pathogenesis of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and
other forms of interstitial lung disease, involves a complex interplay of various factors …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease of pulmonary scarring. New
treatments slow disease progression and allow pulmonary fibrosis patients to live longer …

Background Mediastinal lymph node enlargement is prevalent in patients with idiopathic
pulmonary fibrosis (IPF). Studies investigating whether this phenomenon reflects specific …

Fibrosis is a pathological tissue repair activity in which many myofibroblasts are activated
and extracellular matrix are excessively accumulated, leading to the formation of permanent …

Mesenchymal cells in the lung are crucial during development, but also contribute to the
pathogenesis of fibrotic disorders, including idiopathic pulmonary fibrosis (IPF), the most …

The accumulation of senescent cells within tissues is a hallmark of the aging process.
Senescent cells are also commonly present in many age-related diseases and in the cancer …

Management of patients with idiopathic pulmonary fibrosis an... : Current Opinion in Pulmonary
Medicine Management of patients with idiopathic pulmonary fibrosis and lung cancer …

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with a bleak
prognosis. Mounting evidence suggests that IPF shares bio-molecular similarities with lung …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by irreversible
scarring of lung tissue, leading to death. Despite recent advancements in understanding its …

Alveolar epithelial type II cells (AT2s) together with AT1s constitute the epithelial lining of
lung alveoli. In contrast to the large flat AT1s, AT2s are cuboidal and smaller. In addition to …